Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Britschgi

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Opinion in Allergy and Clinical Immunology|July 20, 2002
Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cellsMarkus Britschgi, Werner J Pichler
Archives of Neurology|December 10, 2008
Blood protein signature for the early diagnosis of Alzheimer diseaseMarkus Britschgi, Tony Wyss-Coray
International Review of Neurobiology|August 7, 2007
Systemic and acquired immune responses in Alzheimer's diseaseMarkus Britschgi, Tony Wyss-Coray
Nature Medicine|April 7, 2007
Immune cells may fend off Alzheimer diseaseMarkus Britschgi, Tony Wyss-Coray
Journal of Neurochemistry|March 2, 2013
Mind the gut: secretion of α-synuclein by enteric neuronsStefan A Grathwohl, Jennifer A Steiner, Markus Britschgi, et al.
Current Drug Targets|January 17, 2003
Molecular aspects of drug recognition by specific T cellsMarkus Britschgi, Salome von Greyerz, Christoph Burkhart, et al.
Cells|February 15, 2022
Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood-Brain Barrier IntegrityDaniel Bull, Christophe Schweitzer, Colette Bichsel, et al.
Journal of Neuroinflammation|September 20, 2012
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in miceMarkus Britschgi, Yoshiko Takeda-Uchimura, Edward Rockenstein, et al.
Molecular Neurobiology|May 1, 2012
Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Carla M Lema Tomé, Trevor Tyson, Nolwen L Rey, et al.
JAMA Neurology|December 15, 2015
Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer DiseaseBenoit Lehallier, Laurent Essioux, Javier Gayan, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Opinion in Allergy and Clinical Immunology|July 20, 2002
Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cellsMarkus Britschgi, Werner J Pichler
Archives of Neurology|December 10, 2008
Blood protein signature for the early diagnosis of Alzheimer diseaseMarkus Britschgi, Tony Wyss-Coray
International Review of Neurobiology|August 7, 2007
Systemic and acquired immune responses in Alzheimer's diseaseMarkus Britschgi, Tony Wyss-Coray
Nature Medicine|April 7, 2007
Immune cells may fend off Alzheimer diseaseMarkus Britschgi, Tony Wyss-Coray
Journal of Neurochemistry|March 2, 2013
Mind the gut: secretion of α-synuclein by enteric neuronsStefan A Grathwohl, Jennifer A Steiner, Markus Britschgi, et al.
Current Drug Targets|January 17, 2003
Molecular aspects of drug recognition by specific T cellsMarkus Britschgi, Salome von Greyerz, Christoph Burkhart, et al.
Cells|February 15, 2022
Generation of an hiPSC-Derived Co-Culture System to Assess the Effects of Neuroinflammation on Blood-Brain Barrier IntegrityDaniel Bull, Christophe Schweitzer, Colette Bichsel, et al.
Journal of Neuroinflammation|September 20, 2012
Deficiency of terminal complement pathway inhibitor promotes neuronal tau pathology and degeneration in miceMarkus Britschgi, Yoshiko Takeda-Uchimura, Edward Rockenstein, et al.
Molecular Neurobiology|May 1, 2012
Inflammation and α-synuclein's prion-like behavior in Parkinson's disease--is there a link?Carla M Lema Tomé, Trevor Tyson, Nolwen L Rey, et al.
JAMA Neurology|December 15, 2015
Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer DiseaseBenoit Lehallier, Laurent Essioux, Javier Gayan, et al.
Pageof 5